Eduardo Reyes

Nigel P. Murray4
Cynthia Fuentealba4
Nelson Orellana3
Jorge Monserrat2
Ruben Olivares2
4Nigel P. Murray
4Cynthia Fuentealba
3Nelson Orellana
2Jorge Monserrat
2Ruben Olivares
Learn More
INTRODUCTION Given the pivotal role of T lymphocytes in the immune system, patients with septic shock may show T cell abnormalities. We have characterised the T cell compartment in septic shock and assess its clinical implications. METHODS T lymphocytes from the peripheral blood of 52 patients with septic shock and 36 healthy control subjects were(More)
INTRODUCTION Although 90% of prostate cancer is considered to be localized, 20%-30% of patients will experience biochemical failure (BF), defined as serum PSA >0.2 ng/mL, after radical prostatectomy (RP). The presence of circulating prostate cells (CPCs) in men without evidence of BF may be useful to predict patients at risk for BF. We describe the(More)
Introduction. Developments in immunological and quantitative real-time PCR-based analysis have enabled the detection, enumeration, and characterization of circulating tumor cells (CTCs). It is assumed that the detection of CTCs is associated with cancer, based on the finding that CTCs can be detected in all major cancer and not in healthy subjects or those(More)
In agreement with McDunn and Hotchkiss [1], we hypothesized that the simultaneous analysis of different immune system cell subsets would improve the prediction of outcome in septic shock patients. Abnormal redistribution of T-lymphocyte, NK-lymphocyte and B-lymphocyte subsets has been found to be involved in the pathogenesis of other diseases, but the(More)
INTRODUCTION Around 90% of prostate cancers detected using the serum prostate specific antigen (PSA) as a screening test are considered to be localised. However, 20-30% of men treated by radical prostatectomy experience biochemical failure within two years of treatment. The presence of primary circulating prostate cells (CPCs) in the blood of these men(More)
Objective. To determine if primary circulating prostate cells (CPCs) are found in all men with prostate cancer. Methods and Patients. A prospective study, to analyze all men with an elevated PSA between 4.0 and 10.0 ng/mL undergoing initial biopsy. Primary CPCs were obtained by differential gel centrifugation and detected using standard immunocytochemistry(More)
Hypernephroma can present as a variety of paraneoplastic, nonmetastatic conditions, including vasculitis, and rarely a lupus-type anticoagulant. Nephrectomy leads to the resolution of the systemic complaints. Malignancy, in this case hypernephroma, can present as an immune-mediated paraneoplastic syndrome which resolves after removal of the underlying tumor.
  • 1